NAD+ 500mg

$109.99

NAD+ 500mg — a nicotinamide adenine dinucleotide research compound, supplied as lyophilised powder for in vitro and laboratory research. COA-verified purity; certificates of analysis are published on this site. Not for human consumption, clinical, or veterinary use.

Supplied for laboratory research use only. Orders are accepted from research institutions, licensed researchers, universities and laboratory R&D purchasers. Not for human or veterinary use.

Discount per Quantity

Quantity2 - 56 - 78 - 910 +
Discount5%10%15%25%
Price$104.49$98.99$93.49$82.49

13 in stock

Free Shipping over $200

Orders ship within 24 hours

Further reading

Reference articles on identity, analysis and Canadian research-use status. They describe how these materials are characterised, not how they are used.

Description

NAD+ 500mg – Research-Grade Peptide for Cellular and Receptor Pathway Studies

Delivery: Laboratory Research-Grade, 500mg Vial

NAD+ 500mg is a research-grade compound developed for laboratory investigations into cellular energetics, mitochondrial function, and enzymatic cofactor activity. It is commonly used in in vitro and ex vivo studies examining cellular energetics, NAD+ pathway modulation, and molecular biology research.

This product is strictly intended for research purposes only and is not approved for human consumption, clinical, or veterinary use.


What Is NAD+?

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme present in all living cells, involved in numerous receptor-signalling and enzymatic processes. In laboratory settings, NAD+ is studied to investigate:

• Cellular energetics and ATP production
• Mitochondrial function and signaling
• Enzymatic cofactor activity, including sirtuin-related pathways
• Molecular and cellular mechanisms of redox reactions
• Dose-response, stability, and biochemical pathway modulation

All applications are strictly non-clinical and limited to scientific research.


Research Applications of NAD+ 500mg

NAD+ 500mg is suitable for laboratory research, including:

• Receptor Pathway Studies – Investigation of NAD+-dependent enzymatic activity and cellular energetics
• Mitochondrial Research – Exploration of NAD+ roles in mitochondrial function and cellular energetics
• Cellular Biochemistry – Studies of redox reactions, cofactor interactions, and receptor signalling
• Molecular Biology Experiments – Analysis of NAD+-related signaling in cell and tissue models
• Dose-Response & Stability Studies – Laboratory evaluation of NAD+ kinetics, stability, and pathway modulation

All uses are strictly limited to scientific research purposes only.


Product Specifications

• Compound: NAD+ (Nicotinamide Adenine Dinucleotide)
• Concentration: 500mg per vial
• Grade: Research-Grade
• Storage: Store according to standard peptide and coenzyme laboratory protocols

The 500mg format provides flexibility for medium- to large-scale laboratory studies and dose-response experiments.


Purity & Quality Assurance

ExoLabz compounds are manufactured under strict quality control standards. ExoLabz products undergo independent third-party verification to confirm identity, purity, and content. Results are published on this site.

Researchers may submit the compound for independent verification. If specifications are not met, ExoLabz provides a refund and testing reimbursement, ensuring full research integrity.


Important Legal Disclaimer

For Research Purposes Only

NAD+ 500mg is intended strictly for scientific research and laboratory investigation. It is not approved by the FDA, Health Canada, or any other regulatory authority. This product is not for human consumption, clinical, therapeutic, or veterinary use.

By purchasing this product, the buyer acknowledges and agrees that it will be used exclusively for lawful laboratory research purposes.


Compound identity and specification

Identity data for NAD+, published so the material can be checked against an independent record rather than taken on trust. The formula, mass and registry number below are verified against PubChem and can be looked up directly.

CompoundNAD+
SequenceNot a peptide: nicotinamide adenine dinucleotide, a dinucleotide of nicotinamide mononucleotide and adenosine monophosphate
Molecular formulaC21H27N7O14P2
Molecular mass663.4 g/mol
CAS registry number53-84-9
PubChemCID 5892
Vial content500 mg
Physical formLyophilised powder in a sealed vial
AnalysisThird-party HPLC; the result for this product is published on this page
Supplied forLaboratory research use only

Analytical note — NAD+. This is a nucleotide coenzyme, not a peptide, and peptide methods do not apply to it. It absorbs strongly at 260 nm rather than at the peptide-bond wavelength, and the relevant purity question is the ratio of oxidised NAD+ to reduced NADH and to hydrolysis products, which a peptide-style HPLC report will not address.

Identity references The molecular formula, molecular mass and CAS registry number above are taken from the PubChem record linked in the table, not from a supplier datasheet, so every figure can be checked against an independent source in one click. Sequences are given as reported in the peptide literature, in the one-letter or three-letter convention as appropriate, with any non-standard residue named in full. Where a compound exists in more than one form — a free peptide and a metal complex, a fragment and its parent protein, a modified and an unmodified analog — the form supplied is the one identified here, and the mass on the certificate of analysis is what distinguishes it.

Research Literature

Peer-reviewed studies involving this compound and its class. All findings listed are from in vitro, cell culture or animal models and are provided for scientific reference only. This product is supplied for laboratory research and is not approved for human consumption, clinical, or veterinary use.

  • Canto C, et al. Cell Metab. 2012;15(6):838-847. In mammalian cells and mouse skeletal muscle and brown adipose tissue, measured tissue NAD+ levels and SIRT1/SIRT3 target deacetylation. Source · PMID 22682224
  • Gomes AP, et al. Cell. 2013;155(7):1624-1638. In aged mouse skeletal muscle, measured nuclear NAD+ decline, normoxic HIF-1alpha accumulation and loss of mtDNA-encoded OXPHOS subunits. Source · PMID 24360282
  • Mills KF, et al. Cell Metab. 2016;24(6):795-806. In C57BL/6N mice over 12 months, measured tissue NAD+ synthesis, cellular energetics, insulin sensitivity and skeletal-muscle mitochondrial oxidative capacity. Source · PMID 28068222

Literature notes: These studies concern NAD+ precursors (nicotinamide riboside and nicotinamide mononucleotide) rather than NAD+ administered directly.

The third-party report for this material is published on this page, and every certificate we hold is collected on the certificates of analysis page.

Browse more compounds in Mitochondrial & Cellular Compounds, or view the full research peptide catalogue.

Additional information

Weight0.01 kg
Dimensions4.5 × 1.6 × 4.5 cm

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.